About: Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2010 (uk) im August 2010 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q58879954-2B66CE33-6787-42B1-A68C-B993AD26098D
publication date	2010-08-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q58879954-068C89C5-CA3F-4E7C-B214-629380CF4A29 wds:Q58879954-81E23255-6B68-4866-AC70-FB5A806781A9
author name string	Eelko Hak Mark H Rozenbaum
rdfs:label	Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands (en) Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands (nl)
skos:prefLabel	Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands (en) Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands (nl)
name	Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands (en) Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged ≥65 years in the Netherlands (nl)
author	wds:Q58879954-A8E704BB-E882-48B0-B2C9-472610C3C82C wds:Q58879954-C21CFBC1-C4C0-48CD-BE15-A6EFB290976D
author	Tjip S van der Werf Maarten J. Postma
title	wds:Q58879954-4C442917-8F4A-4297-9020-D2CD69BFAB5D
title	Results of a cohort model analysis of the cost-effectiveness of routine immunization with 13-valent pneumococcal conjugate vaccine of those aged > or =65 years in the Netherlands (en)
page(s)	wds:Q58879954-794CE46C-49D9-4D89-9E70-357B59AC2313
page(s)	1517-1532
instance of	wds:Q58879954-3E4FFFCB-D057-4130-B2FA-17374B35B480
instance of	scholarly article
main subject	wds:Q58879954-1FF92FA0-2049-4040-9AFF-B8F2437E20FB wds:Q58879954-2DA6C764-94FC-4371-AA52-A66BC394D826 wds:Q58879954-924DE781-E66B-4FA9-BE97-BD9A02DAF15D wds:Q58879954-DF63E57E-04D6-49DA-9C46-A7E66F5A6515
main subject	vaccine pneumococcal conjugate vaccine immunization cost-effectiveness analysis
PubMed ID	wds:Q58879954-18DE8A2F-0414-4FCB-A63A-080AB67E52A3
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20728764
PubMed ID	20728764
published in	wds:Q58879954-D8FC61C7-3668-4D83-9810-5FB6FABE4466
published in	Clinical Therapeutics
issue	wds:Q58879954-A0F44D5D-FEE8-48BC-9714-3F49C0270A5B
volume	wds:Q58879954-5048F168-C7CF-4ECD-AA46-26CAD17DB5E6
issue	8
volume	32
DOI	wds:Q58879954-CE0D97F3-C963-4359-AEE4-37CCA70B4012
DOI	http://dx.doi.org/10.1016/J.CLINTHERA.2010.06.016
DOI	10.1016/J.CLINTHERA.2010.06.016
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58879954
is cites work of	Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis Budget impact analysis of a pneumococcal vaccination programme in the 65-year-old Spanish cohort using a dynamic model Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy Cost–effectiveness of vaccinating adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) in Germany Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice. Cost-effectiveness of vaccination against meningococcal B among Dutch infants: Crucial impact of changes in incidence. The impact of community-acquired pneumonia on the health-related quality-of-life in elderly Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis. Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around.... Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): in older adults A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly Comorbid risk, respondent characteristics and likelihood of pneumococcal vaccination versus no vaccination among older adults in Brazil. Vaccination in the elderly: what can be recommended? The full benefits of adult pneumococcal vaccination: A systematic review. Economic Evaluation of Immunisation Programme of 23-Valent Pneumococcal Polysaccharide Vaccine and the Inclusion of 13-Valent Pneumococcal Conjugate Vaccine in the List for Single-Dose Subsidy to the Elderly in Japan Risk and outcomes of invasive pneumococcal disease in adults with underlying conditions in the post-PCV7 era, The Netherlands Assessment of vaccine candidates for persons aged 50 and older: a review Evaluating the costs and benefits of pneumococcal vaccination in adults. 13-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults Economic studies applied to vaccines against invasive diseases: An updated budget impact analysis of age-based pneumococcal vaccination strategies in the elderly in Italy Inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used. Pneumococcal population in the era of vaccination: changes in composition and the relation to clinical outcomes Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands. Cost-effectiveness analysis on elderly pneumococcal vaccination in the Netherlands: Challenging the Dutch Health Council's advice
is cites work of	wds:Q37478401-3FEAF893-B6ED-4A11-BE48-8DE6C99100FB wds:Q36307771-46C2DA3F-3EFD-4060-B227-4430420BB6D0 wds:Q36295092-0A9DD334-CE94-412E-9685-14460E536174 wds:Q36571135-07B7404A-F313-4C68-9889-4A22496B5358 wds:Q38068468-2BD12B5C-0957-47C8-ABD5-4FA74D1EAD83 wds:Q47098784-03479591-FC3A-4817-A192-C2869501F755 wds:Q38934158-B65A5ACD-4EAB-475C-AB20-20D9ECE02EAD wds:Q54486213-BE07B3F6-80C1-4420-8823-D26D1C2BEA07 wds:Q26999313-F14F27ED-8BF6-4494-84E0-6A0923318D32 wds:Q38966828-9CBD9E9A-EAA6-4916-AF46-3C9643F77931 wds:Q38931440-E46E6418-DA75-47B4-BC67-13054630601C wds:Q38067619-631F4835-9F7A-40B3-993B-06304144FC9A wds:Q34668826-1E13D989-D980-4E74-BED6-5C0ADB0CAD4F wds:Q38167294-AE3383E9-4179-4ACC-BCDA-9875E39930EE wds:Q58286129-11F90102-A8B0-4706-9AD7-091D44B9FBCA wds:Q38082673-BD049F35-0650-4F1E-A342-7B9D459551E2 wds:Q40932197-22127190-5768-4693-BD98-304D49154A77 wds:Q38698467-B1B7F10F-63E5-4D30-BF6C-1A38AE104948 wds:Q39124135-7AE7877A-FA84-43AD-B649-7E9F1AC8D2C1 wds:Q47583090-19D2A27E-2108-4E5D-A30A-9543E9B4D5B7 wds:Q38560859-80EA36A7-1117-4486-A77A-5F8F70144D2D wds:Q37505414-74206A0C-5598-4B35-8CBE-337D28BB4085 wds:Q38220158-426F3060-94DD-47C9-BBF3-FF28294A9B90

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software